Material efficiency is one of basic challenges for any lab. To improve your lab, simply use less material. This is also ...

10x Genomics, Inc. (NASDAQ: TXG) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It has announced a ...

The global bloodstream infection testing market size was US$ 5.1 billion in 2021. The global bloodstream infection testing market size is estimated to reach US$ 12.9 billion by 2030, growing at a ...

ETTLINGEN, Germany - Bruker Corporation (NASDAQ:BRKR), a scientific instruments manufacturer with a market capitalization of $5.6 billion, has introduced the MOVE-T, an innovative liquid dairy ...

10x Genomics has settled patent infringement lawsuits with a pair of rivals, Bruker and Vizgen, through settlements that could reshape competition within the emerging single-cell and spatial ...

Nanostring, a publicly listed company when the lawsuit was filed, went bankrupt in February 2024. Bruker acquired the company a month later for $392.6m, and inherited the lawsuit.

The settlement includes global patent cross-licenses and a complete withdrawal of all legal proceedings, including those in the United States, Germany and before the European Unified Patent Court.

Bruker Corporation (Nasdaq: BRKR) today announced that Bruker and 10x Genomics have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent ...

Bruker and 10x Genomics have agreed to settle a patent dispute relating to products originally developed by Nanostring, a company Bruker acquired in 2024. Under the settlement, whose financial terms ...

10x Genomics Inc. and Bruker Corp. agreed to dismiss a federal lawsuit over genetic-mapping patents more than a year after 10x won a $31 million infringement award from a company Bruker later acquired ...

Bruker Corporation (NASDAQ: BRKR) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Joe Kostka – Director-Investor Relations Frank Laukien – President and Chief ...

Bruker reported Q1 2025 revenue of $801.4 million, representing an 11.0% increase from $721.7 million in Q1 2024. This growth was primarily driven by acquisitions, which contributed 9.6% to the ...